Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Caredx Inc
(NQ:
CDNA
)
15.13
-0.50 (-3.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Caredx Inc
< Previous
1
2
3
4
5
6
7
8
Next >
CareDx Applauds District Court Decision to Uphold Jury Verdict that Natera Falsely Advertised its Prospera Transplant Test
July 17, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx’s AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring
July 11, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Demonstrates Innovation Leadership at 2023 Transplant Congress
June 01, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx to Participate in Upcoming Investor Conferences
June 01, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management Forum
May 16, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Reports First Quarter 2023 Results
May 10, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx to Report First Quarter 2023 Financial Results
May 08, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference
April 25, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation
April 19, 2023
From
CareDx, Inc.
Via
Business Wire
National Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant Community
April 06, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
April 05, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
April 05, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association
March 23, 2023
From
CareDx, Inc.
Via
Business Wire
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
March 10, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
The American Society of Transplant Surgeons Position Statement Supports Use of CareDx’s AlloSure Kidney for Organ Transplant Surveillance
March 07, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Update Regarding Raymond James & Associates’ Conference
March 06, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx To Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference
March 06, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Comments on MolDX Publication of New Billing and Coding Article
March 03, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Key Supporter of the National Kidney Foundation’s Annual Kidney Patient Summit
March 01, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Fourth Quarter and Full Year 2022 Results
February 27, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation Meeting
February 22, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx to Report Fourth Quarter and Full Year 2022 Financial Results
February 21, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Showcases Latest Advancements in Cellular Transplant and Therapy Including Specialized Digital Health Solutions at the 2023 Tandem Meetings
February 16, 2023
From
CareDx, Inc.
Via
Business Wire
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
February 13, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
JACC Publication Guides Use of CareDx’s HeartCare Transplant Rejection Surveillance in Clinical Practice
January 26, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Fosters Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium
January 11, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022
January 09, 2023
From
CareDx, Inc.
Via
Business Wire
CAREDX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CareDx, Inc. - CDNA
December 30, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
New ISHLT Guidelines Support Use of CareDx’s HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients
December 21, 2022
From
CareDx, Inc.
Via
Business Wire
CareDx Announces $50 Million Stock Repurchase Program
December 06, 2022
From
CareDx, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.